• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, January 2, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Surgery unnecessary for many prostate cancer patients

Bioengineer by Bioengineer
December 16, 2018
in Cancer
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian men with prostate cancer for 29 years. The results are now published in The New England Journal of Medicine.

The research findings now presented are from the 29-year follow-up of the Scandinavian Prostate Cancer Group Study Number Four (SPCG-4), investigating the benefits of surgery for prostate cancer. The study comprised 695 men who were randomly assigned to two groups, one to get surgical treatment and the other to receive treatment of symptoms only (“watchful waiting”).

The men in this study were diagnosed between 1989 and 1999. Only a few (12 per cent) of them had their cancer detected early by having their blood tested for prostate-specific antigen (PSA). The study was carried out during the period before large-scale use of the PSA test began in Scandinavia.

After 29 years’ follow-up, 80 per cent of the men had died. For 32 per cent of these, death was due to prostate cancer. Seventy-one men in the surgery group died of prostate cancer, while 110 did so in the group receiving symptom treatment only. The study showed that 12 per cent of those who had prostatectomies had been saved from dying of prostate cancer; that 19 per cent had incurable cancer; but that the majority of the men had died of other causes. The results also showed that the men who had been operated on lived, on average, 2.9 years longer than the men who received treatment of symptoms only.

It is evident from the study that men who are otherwise healthy and whose advanced prostate cancer is confined to the prostate gland alone may benefit greatly from the surgery. Nevertheless, it was also found that, despite their diagnoses of prostate cancer, many men never suffered from a serious relapse during their lives, nor died from the disease. For the treatment to be optimally beneficial for men with prostate cancer, it is therefore crucially important to find the correct balance between the benefit from prostatectomy, on the one hand, and its side-effects on the other.

Through PSA, many men are now being diagnosed with prostate cancer who will never develop advanced or life-threatening symptoms. Compared with the 1990s, more men with prostate cancer should thus be actively followed up and treated only if signs of advanced cancer are present.

###

Media Contact
Dr. Anna Bill-Axelsson
[email protected]
46-701-679-747
http://dx.doi.org/10.1056/NEJMoa1807801

Tags: cancerMedicine/HealthProstate CancerSurgery
Share12Tweet8Share2ShareShareShare2

Related Posts

Derazantinib Boosts Gemcitabine by Blocking MUC5AC

December 30, 2025

FOCUS Study Reveals Insights on Melphalan for Uveal Melanoma

December 29, 2025

Black Grape Anthocyanins Boost 5-FU Cancer Therapy

December 29, 2025

Girdin Silencing Boosts Mebendazole’s Ovarian Cancer Fight

December 29, 2025
Please login to join discussion

POPULAR NEWS

  • blank

    PTSD, Depression, Anxiety in Childhood Cancer Survivors, Parents

    113 shares
    Share 45 Tweet 28
  • NSF funds machine-learning research at UNO and UNL to study energy requirements of walking in older adults

    71 shares
    Share 28 Tweet 18
  • Exploring Audiology Accessibility in Johannesburg, South Africa

    52 shares
    Share 21 Tweet 13
  • SARS-CoV-2 Subvariants Affect Outcomes in Elderly Hip Fractures

    44 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Advancements in Droplet Microfluidics for Biomaterials

Topological Vertical Cavity Lasers from Soft Matter

Advancements in cGAS-STING Signaling and Immune Cell Infiltration

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 71 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.